Erste Group upgraded Eli Lilly (LLY) to Buy from Hold. Eli Lilly has products that are in high demand as well as “an extensive pipeline of potentially successful products,” says the analyst, who adds that possible price reductions for “important products” Mounjaro and Zebound will not be negotiated until 2029 at the earliest.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LLY:
Questions or Comments about the article? Write to editor@tipranks.com